SCHEMBL56633

SCHEMBL56633

C1CC2CNCC1N2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17652515 1.00
SCHEMBL1947185 1.00
SCHEMBL23253901 1.00
SCHEMBL5965697 0.96
Hydrochloric Acid SCHEMBL5241311 0.96 CCR5 (0.35)
Nitric Oxide SCHEMBL5965613 0.90 CCR5 (0.32)
SCHEMBL702038 0.86
SCHEMBL23505391 0.86
SCHEMBL1449497 0.86 CCR5 (0.33)
SCHEMBL8273900 0.84

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 3048 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122070278-A Bifunctional protein degradation agent containing aryl substituted heteroaryl and application thereof 标新生物医药科技(上海)有限公司 2026-05-19 CN claimed
US-20260124198-A1 ANTIVIRAL PYRAZOLOPYRIDINONE COMPOUNDS GILEAD SCIENCES INC (US) 2026-05-07 US claimed
EP-4695256-A2 ERBB2 INHIBITORS Cogent Biosciences, Inc. (US) 2026-02-18 EP claimed
US-20260042770-A1 NOVEL SULFONES AND THEIR USE AS NEUROPROTECTIVE AND/OR NEURORESTORATIVE AGENTS GENECODE (EE) 2026-02-12 US claimed
US-20260022096-A1 NOVEL SULFONAMIDES AND THEIR USE AS NEUROPROTECTIVE AND/OR NEURORESTORATIVE AGENTS GENECODE (EE) 2026-01-22 US claimed
WO-2025215121-A1 HEDGEHOG ACYLTRANSFERASE INHIBITORS IMPERIAL COLLEGE INNOVATIONS LIMITED (GB) 2025-10-16 WO claimed
US-20250263412-A1 NON-HYDROXAMATE HDAC6 INHIBITORS AND RELATED METHODS OF USE THE REGENTS OF THE UNIVERSITY OF MICHIGAN 2025-08-21 US claimed
CN-120202200-A Oxo-isoindolinyl substituted tetrahydropyrimidinedione-based compounds and applications thereof 标新生物医药科技(上海)有限公司 2025-06-24 CN claimed
US-20250129078-A1 ERBB2 INHIBITORS COGENT BIOSCIENCES, INC. 2025-04-24 US claimed
EP-4308576-B1 NEW THIAZOLOPYRIMIDINONE DERIVATIVES HOFFMANN LA ROCHE (CH) 2025-04-23 EP claimed
EP-1993554-A2 UROTENSIN II RECEPTOR ANTAGONISTS Janssen Pharmaceutica, N.V. (BE) 2008-11-26 EP claimed
WO-2008094992-A2 2-AMINOPYRIDINE DERIVATIVES USEFUL AS KINASE INHIBITORS VERTEX PHARMACEUTICALS INCORPORATED (US) 2008-08-07 WO claimed
US-20070191391-A1 Urotensin II receptor antagonists JANSSEN PHARMACEUTICA N.V. (BE) 2007-08-16 US claimed
WO-2007081995-A2 UROTENSIN II RECEPTOR ANTAGONISTS JANSSEN PHARMACEUTICA, N.V. (BE) 2007-07-19 WO claimed
US-20050054653-A1 Pteridine derivatives, method of producing them and their application FAUSTUS FORSCHUNGS CIE. TRANSLATIONAL CANCER RESEARCH GMBH 2005-03-10 US claimed
EP-1467994-A1 PTERIDINE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF, AND USE THEREOF Faustus Forschungs Cie. Translational Cancer Research GmbH (DE) 2004-10-20 EP claimed
WO-2003062240-A1 PTERIDINE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF, AND USE THEREOF FAUSTUS FORSCHUNGS CIE. TRANSLATIONAL CANCER RESEARCH GMBH (DE) 2003-07-31 WO claimed
EP-0746560-A1 3,8-DIAZABICYCLO 3.2.1]OCTANE DERIVATIVES HAVING ANALGESIC ACTIVITY RIACE ESTABLISHMENT (LI) 1996-12-11 EP claimed
WO-1995023152-A1 3,8-DIAZABICYCLO[3.2.1]OCTANE DERIVATIVES HAVING ANALGESIC ACTIVITY RIACE ESTABLISHMENT (LI) 1995-08-31 WO claimed
US-5185320-A Antibiotics GRUPPO LEPETIT S.P.A. (IT) 1993-02-09 US claimed